The Evolving Role of Biomarkers in Personalized Lung Cancer Therapy
Janaki Sharma(Albert Einstein College of Medicine), Balázs Halmos(Montefiore Medical Center), Daniel Paucar(Albert Einstein College of Medicine), Vincent Chau(Eli Lilly (United States)), Haiying Cheng(Karlsruhe Institute of Technology), Elaine Shum(NYU Langone’s Laura and Isaac Perlmutter Cancer Center)
Cited by 11
Related Papers
Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2018|3.7k
Role of the Ubiquitin-Proteasome Pathway in Regulating Abundance of the Cyclin-Dependent Kinase Inhibitor p27
|Science|1995|1.8k
Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel–Lindau protein
|Nature Cell Biology|2000|1.6k
A Multiubiquitin Chain Is Confined to Specific Lysine in a Targeted Short-Lived Protein
|Science|1989|1.5k
Update 2020: Management of Non-Small Cell Lung Cancer
|Lung|2020|649